Tag Archives: tsx

Lobe Sciences Ltd presents at Proactive's One2One virtual investor forum

Lobe Sciences Ltd (CSE:LOBE) (OTCMKTS:GTSIF)CEO Philip Young presents at Proactive’s One2One virtual investor forum. The Vancouver-based company is currently advancing unique medicines and devices to treat mild traumatic brain injury and post-traumatic stress disorder, as well as other indications. With five provisional patents, a pre-clinical study underway and a drug delivery device in engineering development,… Read More »

Lobe Sciences to present at Proactive's One2One Virtual Investor Forum on February 23

Lobe Sciences (CSE: LOBE) CEO Philip Young tells Proactive he’s looking forward to presenting at Proactive’s One2One Virtual Investor Forum on February 23, at 1pm EST. Young says he hopes investors understand how the group has made the transition to a fully-integrated psychedelics company from a cannabis company. He expects to expand upon the group’s… Read More »